SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) announced today that it has manufactured and shipped Hemopurifier® treatment cartridges for studies related to the treatment of Dengue Hemorrhagic Fever (DHF), an international health issue untreatable with antiviral drug and vaccine therapy. The Hemopurifier® studies are being performed by researchers at the National Institute of Virology (NIV), the Government of India’s leading infectious disease research center and collaborating laboratory of the World Health Organization (WHO).
